An 8-year pragmatic observation evaluation of the benefits of allogeneic HCT in older and medically infirm patients with AML
Mohamed L. Sorror(University of Washington Medical Center), Elihu H. Estey(University of Washington), Lynn Onstad(Fred Hutch Cancer Center), Aaron T. Gerds(Cleveland Clinic), Ted Gooley(Fred Hutch Cancer Center), Jeannine S. McCune(City of Hope), Stephanie J. Lee(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Tammy A. Schuler(Fred Hutch Cancer Center), Eunice S. Wang(Roswell Park Comprehensive Cancer Center), Mitchell Garrison(Wenatchee Valley Hospital & Clinics), Maria R. Baer(University of Maryland, Baltimore), Pamela S. Becker(City Of Hope National Medical Center), Jamie Koprivnikar(Hackensack University Medical Center), Mikkael A. Sekeres(University of Miami), Frederick R. Appelbaum(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), David A. Rizzieri(Duke University), Wendy M. Leisenring(The University of Texas MD Anderson Cancer Center), Barry E. Storer(City Of Hope National Medical Center), Kehinde Adekola(Northwestern Memorial Hospital), Kiarash Kojouri(Skagit Valley Hospital), Tanya M. Wildes(University of Nebraska Medical Center), Brenda M. Sandmaier(University of Washington), Paul J. Shami(University of Utah), Bruno C. Medeiros(Stanford Medicine), Julie Smith(University of Strathclyde), Selina M. Luger(University of Pennsylvania)
Cited by 33
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Chronic Health Conditions in Adult Survivors of Childhood Cancer
|New England Journal of Medicine|2006|3.6k